[go: up one dir, main page]

DE10257478A1 - Composition containing antioxidants and micronutrients, useful for treatment or prevention of paradontitis and associated disorders, also osteoporosis - Google Patents

Composition containing antioxidants and micronutrients, useful for treatment or prevention of paradontitis and associated disorders, also osteoporosis Download PDF

Info

Publication number
DE10257478A1
DE10257478A1 DE10257478A DE10257478A DE10257478A1 DE 10257478 A1 DE10257478 A1 DE 10257478A1 DE 10257478 A DE10257478 A DE 10257478A DE 10257478 A DE10257478 A DE 10257478A DE 10257478 A1 DE10257478 A1 DE 10257478A1
Authority
DE
Germany
Prior art keywords
composition according
osteoporosis
vitamin
treatment
periodontitis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE10257478A
Other languages
German (de)
Inventor
Ulrich Dahlhaus
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dahlhaus Ulrich Dr
Original Assignee
Dahlhaus Ulrich Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dahlhaus Ulrich Dr filed Critical Dahlhaus Ulrich Dr
Priority to DE20220964U priority Critical patent/DE20220964U1/en
Priority to DE10257478A priority patent/DE10257478A1/en
Publication of DE10257478A1 publication Critical patent/DE10257478A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12Fatty acids or derivatives thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15Vitamins
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16Inorganic salts, minerals or trace elements
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • A61K31/122Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/18Iodine; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/26Iron; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/30Zinc; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/32Manganese; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/34Copper; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/42Phosphorus; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35Ketones, e.g. benzophenone
    • A61K8/355Quinones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52Stabilizers
    • A61K2800/522Antioxidants; Radical scavengers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Birds (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Botany (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Die Anmeldung betrifft eine Zusammensetzung, umfassend einen Gehalt an Antioxidantien und Vitalstoffen sowie geeignete Hilfs- und Trägerstoffe zur prophylaktischen und/oder akuten Behandlung von Parodontitis sowie damit einhergehenden Begleit- und/oder Folgeerkrankungen.The application relates to a composition comprising a content of antioxidants and vital substances as well as suitable auxiliaries and carriers for the prophylactic and / or acute treatment of periodontitis as well as accompanying and / or secondary diseases associated therewith.

Description

Die vorliegende Erfindung betrifft eine Zusammensetzung zur prophylaktischen und/oder akuten Behandlung von Parodontitis sowie damit einhergehenden Begleit- und/oder Folgeerkrankungen.The present invention relates to a composition for prophylactic and / or acute treatment of periodontitis as well as accompanying and / or secondary diseases.

In Deutschland lag 1999 die Häufigkeit behandlungsbedürftiger Parodontitiden bei über 75 % und zählen weltweit – nach Karies – zu den am meisten verbreiteten Erkrankungen.The frequency was in Germany in 1999 requiring treatment Periodontitis in over 75% and count worldwide - after Caries - too the most common diseases.

Chronische Zahnfleischentzündungen können die Ursache verschiedener Erkrankungen sein. Bei chronischen Erkrankungen von Zahnfleisch und Zahnbett dringen Entzündungen auslösende Bakterien auch in die Blutgefäße ein. Dort aktivieren sie immunkompetente Zellen der körpereigenen Abwehrkräfte. Auf diesen Reiz hin produzieren die alarmierten Immunzellen dann Zytokine, d.h. zerstörerische Botenstoffe, die im gesamten Organismus andere Gewebe und Organe schädigen können.Chronic gum infections can be the cause of various diseases. With chronic diseases Inflammatory bacteria penetrate the gums and the tooth bed also in the blood vessels. There they activate immune-competent cells of the body's defenses. On the alarmed immune cells then produce this stimulus, cytokines, i.e. destructive Messenger substances that spread to other tissues and organs throughout the organism damage can.

Beispielsweise können in der Bauchspeicheldrüse die für die Insulinproduktion verantwortlichen Zellen durch permanent erhöhte Zytokinspiegel geschädigt oder sogar zerstört werden. Wenn das der Fall ist, kann Diabetes entstehen. Bakterien, wie Streptococcus sanguis oder Porphyromonas gingivalis können schwere Herzerkrankungen auslösen. Bei Patienten mit fortgeschrittener Parodontitis wurde ein dreifaches Schlaganfallrisiko sowie bei Frauen ein siebenfaches Risiko für Frühgeburten beobachtet.For example, the pancreas can be used for insulin production responsible cells damaged or permanently cytokine levels even destroyed become. If this is the case, diabetes can develop. Bacteria, such as Streptococcus sanguis or Porphyromonas gingivalis can cause serious heart disease trigger. In patients with advanced periodontitis, there was a triple Stroke risk as well as a sevenfold risk of premature birth in women observed.

Aus dem Plaque strömende Enzyme, (z. B. Hyaluronidasen, Kollagenasen und Chondrioitinsulfatasen) Antigene, Endotoxine und Zytokine greifen in das Gewebe ein. Das Gewebe antwortet mit Immunvorgängen, die zu einer Parodontitis und zur Bildung von pathologischen Zahnfleischtaschen, zur Auflösung des Bindege webes mit Knochenabbau, zur Zahnlockerung und letztendlich zum Zahnverlust führen. Das Heimtückische an dieser Erkrankung ist, dass Parodontitis selbst im weit fortgeschrittenen Stadium meist schmerzfrei ist. Die Erkrankung verläuft aufgrund der Verschlechterung der Stoffwechsellage progredient und ist ansteckend.Enzymes flowing out of the plaque, (e.g. hyaluronidases, collagenases and chondrioitinsulfatases) Antigens, endotoxins and cytokines interfere with the tissue. The Tissue responds with immune processes, leading to periodontitis and the formation of pathological gum pockets, for dissolution of the connective tissue with bone loss, for loosening teeth and ultimately lead to tooth loss. The insidious of this disease is that periodontitis is well advanced Stage is usually painless. The disease is due to the deterioration of the metabolism progressively and is contagious.

Es gilt daher ein Mittel zur Verfügung zu stellen, mit welchem man routinemäßig die Entstehung von Parodontitis prophylaktisch entgegenwirken und bereits aufgetretene Parodontitis zurückdrängen kann, um Folgeerkrankungen zu vermeiden.There is therefore a means at your disposal with which one routinely the development of periodontitis counteract prophylactically and periodontitis that has already occurred can push back to avoid complications.

Gegenstand der vorliegenden Erfindung ist demnach eine Zusammensetzung, umfassend einen Gehalt an Antioxidantien und Vitalstoffen sowie geeignete Hilfs- und Trägerstoffe zur prophylaktischen und/oder akuten Behandlung von Parodontitis sowie damit einhergehend Begleit- und/oder Folgeerkrankungen.Object of the present invention is accordingly a composition comprising an antioxidant content and vital substances as well as suitable auxiliary and carrier substances for prophylactic and / or acute treatment of periodontitis and related Concomitant and / or secondary diseases.

Durch die kombinatorische Anwendung von Antioxidantien und Vitalstoffen wird die Stoffwechsellage im oralen Bereich bei – gleichzeitiger Unterdrückung von Entzündungen – optimiert. Die Wirkung ist im Vergleich zur Einzelverabreichung der Komponenten überraschender Weise synergistisch.Through the combinatorial application of antioxidants and vital substances the metabolic situation in the oral area at - simultaneous suppression of inflammation - optimized. The effect is more surprising compared to the individual administration of the components Wise synergistic.

Vorzugsweise weist die Zusammensetzung einen Gehalt an Ubichinon (Q10) und Vitalstoffen, nämlich Vitaminen und/oder Mineralien auf. Die Vitamine umfassen alle gängigen Vitamine der Gruppen A, B, C, D, E und K. Unter den Mineralien sind bevorzugt solche auf Basis von Calcium, Magnesium, Zink, Kupfer, Mangan, Fluor und Phosphor zu erwähnen.Preferably, the composition contains ubiquinone (Q10) and vital substances, namely vitamins and / or minerals. The vitamins include all common vitamins of groups A, B, C, D, E and K. Among the minerals are preferred those based on calcium, magnesium, zinc, copper, manganese, fluorine and mention phosphorus.

Die antibakterielle Wirkung von polyphenolhaltigen Substanzen (z. B. Extrakte von Grünem Tee) führt durch Wachstumshemmung des Bakteriums "Streptokokkus mutans" zur Verbesserung der Zahnfleischqualität und zu einem signifikanten Absinken des Plaqueindexes.The antibacterial effect of polyphenols Substances (e.g. green tea extracts) cause growth inhibition of the bacterium "streptococcus mutans "for improvement the gum quality and a significant decrease in the plaque index.

Weitere vorteilhafte Bestandteile der Zusammensetzungen bilden die Aminosäuren, z. B. in Aloe vera, insbesondere Lysin, die ein wesentlicher Bestandteil des Kollagens, der Sehnen, Knochen und Zähne ist. Lysin blockt die eiweißverdauenden Enzyme (Proteasen) und vermindert somit den Abbau von Zahnfleisch.Other beneficial ingredients the compositions form the amino acids, e.g. B. in aloe vera, in particular Lysine, which is an essential part of collagen, the tendons, Bones and teeth is. Lysine blocks the protein-digesting Enzymes (proteases) and thus reduces the breakdown of gums.

Die erfindungsgemäßen Zusammensetzungen finden demnach bevorzugt Verwendung in der Therapie bei akuten und chronischen Zahnfleisch- und Kiefererkrankungen, bei Osteoporose insbesondere der Osteoporoseprävention. Die Zusammensetzung kann im human- und veterinärmedizinen Bereich in Form von Pasten, Ölen oder in Form von Lutschtabletten Verwendung finden.Find the compositions of the invention therefore preferred use in therapy for acute and chronic Gum and jaw diseases, especially with osteoporosis prevention of osteoporosis. The composition can be in the form of human and veterinary medicine of pastes, oils or in the form of lozenges.

Bevorzugte Zusammensetzungen, in Form einer Paste, eines Öls und einer Lutschtablette, sind im Folgenden beispielhaft angegeben. Paste (wirksamer Gehalt an Wirkstoff pro 100 g) Q10 0,001–10,0 Gew% (1 mg–10 g) Vit C 0,5–15 Gew% (500 mg–15 g) Vit E 0,01–10,0 Gew% (10 mg–10 g) B-Carotin (Öl) 0,001–5,0 Gew% (1 mg–5 g) Vit B5 (Panthetin) 0,01–5,0 Gew% (10 mg–5 g) Omega 3 FS 0–60,0 Gew% (0–60 g) Vit D (Ol jecoris) 0–5,0 Gew% (0–5 g) Propolis 0–10,0 Gew% (0–10 g) Malaleuca-Alternifolia 0–5,0 Gew% (0–5 g) Magnesiumfluorid 0–0,5 Gew% (0–500 mg) Zinkfluorid 0–0,1 Gew% (0–100 mg) Polyphenole 0–2,0 Gew% (0–2 g) Lysin 0–2,0 Gew% (0–2,0 g) Aloe vera 0–10 Gew% (0–10 g) Preferred compositions, in the form of a paste, an oil and a lozenge, are given below by way of example. paste (effective content of active ingredient per 100 g) Q10 0.001-10.0% by weight (1 mg-10 g) Vit C 0.5-15% by weight (500 mg-15 g) Vit E 0.01-10.0% by weight (10 mg-10 g) B-carotene (oil) 0.001-5.0% by weight (1 mg-5 g) Vit B5 (panthetin) 0.01-5.0% by weight (10 mg-5 g) Omega 3 FS 0-60.0 wt% (0-60 g) Vit D (Ol jecoris) 0-5.0 wt% (0-5 g) propolis 0-10.0% by weight (0-10 g) Malaleuca-alternifolia 0-5.0 wt% (0-5 g) magnesium fluoride 0-0.5% by weight (0-500 mg) zinc fluoride 0-0.1% by weight (0-100 mg) polyphenols 0-2.0% by weight (0-2 g) lysine 0-2.0% by weight (0-2.0 g) Aloe vera 0-10% by weight (0-10 g)

Gegebenenfalls kann diese Pastenzusammensetzung Poliermittel und/oder Geschmacksstoffe sowie Trägerstoffe bzw. Bindemittel beinhalten.
Poliermittel: beispielsweise Dicalciumphosphat-dihydrat
Geschmacksstoffe:
Öle aus Salbei, Zitrone, Pfefferminz, Menthol und/oder Nelke.
Trägerstoffe/Bindemittel:
Agar-Agar oder Kieselsäuren, wie Aerosil® Öl (wirksamer Gehalt an Wirkstoff pro 100 g) Q10 0–80 Gew% 01 jecoris 0–70 Gew% Vitamin E 0–50 Gew% Vitamin C 0–70 Gew% Lutschtablette (wirksamerGehalt an Wirkstoff pro 100 g) Q10 0–10 g bzw. –20% Vit C 0–10 g bzw. –10% Vit E 0–10 g bzw. –10% Mg 0–5 g bzw. –5% Polyphenole 0–5 g bzw. –5%
If appropriate, this paste composition can contain polishing agents and / or flavorings as well as carriers or binders.
Polishing agent: for example dicalcium phosphate dihydrate
Flavorings:
Sage, lemon, peppermint, menthol and / or clove oils.
Excipients / Binder:
Agar or silica, such as Aerosil ® oil (effective content of active ingredient per 100 g) Q10 0-80% by weight 01 jecoris 0-70% by weight Vitamin E. 0-50% by weight vitamin C 0-70% by weight lozenge (effective content of active ingredient per 100 g) Q10 0–10 g or –20% Vit C 0–10 g or –10% Vit E 0–10 g or –10% mg 0-5 g or -5% polyphenols 0-5 g or -5%

Die positiven Wirkungen der oben angegebenen Zusammensetzungen beruhen auf einer Entkeimung von Mund- und Rachenraum, einer Vorbeugung gegen Entzündungen der Atemwege, einer Unterstützung bzw. Entlastung des Immunsystems, einer Vermeidung und Minderung eines starken Mundgeruches, einer Unterstützung bzw. Therapie bei Zahnfleischentzündungen und, nicht zuletzt, einer prophylaktischen und unterstützenden Therapie bei Osteoporose, insbesondere der Kieferknochen.The positive effects of the above specified compositions are based on a disinfection of oral and throat, a prevention of inflammation of the respiratory tract, one Support or Relief of the immune system, avoidance and reduction of one strong bad breath, support or therapy for gingivitis and, last but not least, a prophylactic and supportive one Therapy for osteoporosis, especially the jawbone.

Q10 ist Teil der Elektronentransportkette, um die bei der Glukosespaltung entstehenden hochenergetischen Elektronen zu neutralisieren und ATP zu gewinnen. Ein Mangel führt zur Senkung der ATP-Produktion und damit der Senkung der Zellerneuerung.Q10 is part of the electron transport chain, around the high-energy electrons generated during glucose cleavage neutralize and gain ATP. A lack leads to Lower ATP production and thus lower cell renewal.

Vitamin C fördert die Neuproduktion von Kollagen und Elastinmolekülen. Dadurch wird eine ausreichende Festigkeit des Bindegewebes erreicht.Vitamin C promotes the new production of Collagen and elastin molecules. This ensures sufficient connective tissue strength.

Unter Osteoporose versteht man den beschleunigten und verfrühten Knochenabbau, besonders der Wirbelsäule, des Oberschenkelhalses und am Alveolarfortsatz des Kieferknochens. Die Erkrankung ist durch eine Verringerung der Knochenmasse und eine Verschlechterung der Mikroarchitektur des Knochens gekennzeichnet. 1999 litten ca. 6 Millionen Menschen an Osteoporose.Osteoporosis is the accelerated and premature Bone breakdown, especially of the spine, the neck of the femur and on the alveolar process of the jawbone. The disease is caused by a Decrease in bone mass and deterioration in micro-architecture of the bone. In 1999, about 6 million people suffered of osteoporosis.

Sollen die erfindungsgemäßen Zusammensetzungen auch zur Osteoporoseprävention dienen, ist es vorteilhaft weitere Vitamine und/oder Vitalstoffe zuzusetzen.Are the compositions of the invention also for the prevention of osteoporosis serve, it is advantageous further vitamins and / or vital substances add.

Im folgenden werden die Wirkungsweisen einiger solcher Komponenten in Kurzform erläutert:
Vitamin D: fördert die Calciumresorption im Darm; ist am Knochenstoffwechsel beteiligt; Defizite bei verminderter Sonnenlichtexposition;
Vitamin D-Versorgung 1. über Nahrung; meistens zu gering
2. Eigenproduktion in der Haut bei UV Licht.
Vitamin B6: Knochen enthält organische Matrix, deren Bestandteile Knochenfibrillen sind. Sie sind für die Elastizität der Knochen verantwortlich.
B6 ist zur Synthese von Knochenkollagen wichtig. Es besteht eine positive Beeinflussung des knochenaufbauenden weiblichen Geschlechtshormons Progesteron.
Mangel: durch Umwelttoxine wie Hydrazine; Verschiedene Herbizide wirken als B6 – Antagonisten.
Vitamin C: Beteiligung an der Synthese des Knochenkollagens; die Kollagenbiosynthese verstärkt die Knochenstabilität;
Aktivierung von Vitamin D
Bei Vitamin C-Mangel: verringerte Knochenbildung; verstärkte Knochenresorption; blutende Gingiva, erklärt durch mangelhafte Kollagensynthese;
Die Vitamin C-Konzentration ist in speziellen weißen Blutzellen, den sog. polymorphkernigen neutrophilen Granulozyten (PMN) 10-80 mal höher als im Blutplasma.
Die Funktion ist:
Aufrechterhaltung der Chemotaxis;
leichtere Oxidation von Mikroorganismen;
antioxidativer Schutz der Membranen der Granulozyten vor freien Radikalen;
Vitamin K: für die Verbindung zwischen anorganischen Mineral salzen und organischer Matrix sind Calcium bindende Proteine verantwortlich. Die Bildung dieser Proteine ist vom Vitamin D und Vitamin K abhängig. Vitamin K ist somit für den Calciumeinbau in den Knochen erforderlich. Vitamin K ist z. B. in Aloe vera enthalten.
Calcium: Hauptbestandteil der anorganischen Knochenmasse als Apatit-Kristall, verantwortlich für die Festigkeit des Knochens; Calcium-Resorption wird vermindert durch phosphatreiche Nahrungsmittel (besonders Wurst- und Fleischwaren); Calciumausscheidung wird verstärkt durch den Genuss von Kaffee, Alkohol, Zigaretten, kochsalzreiche Kost
Kollagenbildung: Vitamin C, Zink, Kupfer und Vitamin B6 sind an der Synthese von Knochenkollagen beteiligt.
The effects of some of these components are briefly explained below:
Vitamin D: promotes calcium absorption in the intestine; is involved in bone metabolism; Deficits with reduced exposure to sunlight;
Vitamin D supply 1. via food; mostly too low
2. Own production in the skin with UV light.
Vitamin B6: Bone contains organic matrix, the components of which are bone fibrils. They are responsible for the elasticity of the bones.
B6 is important for the synthesis of bone collagen. There is a positive influence on the bone-building female sex hormone progesterone.
Deficiency: due to environmental toxins such as hydrazines; Various herbicides act as B6 antagonists.
Vitamin C: participation in the synthesis of bone collagen; collagen biosynthesis enhances bone stability;
Activation of vitamin D.
With vitamin C deficiency: reduced bone formation; increased bone resorption; bleeding gingiva, explained by deficient collagen synthesis;
The vitamin C concentration in special white blood cells, the so-called polymorphonuclear neutrophil granulocytes (PMN), is 10-80 times higher than in blood plasma.
The function is:
Maintenance of chemotaxis;
easier oxidation of microorganisms;
antioxidant protection of the membranes of the granulocytes against free radicals;
Vitamin K: Calcium-binding proteins are responsible for the connection between inorganic mineral salts and the organic matrix. The formation of these proteins depends on vitamin D and vitamin K. Vitamin K is therefore necessary for the calcium incorporation in the bones. Vitamin K is e.g. B. contained in aloe vera.
Calcium: main component of the inorganic bone mass as apatite crystal, responsible for the strength of the bone; Calcium absorption is reduced by foods rich in phosphates (especially sausages and meat products); Calcium excretion is intensified through the enjoyment of coffee, alcohol, cigarettes and high-salt foods
Collagen formation: Vitamin C, zinc, copper and vitamin B6 are involved in the synthesis of bone collagen.

Proteine:proteins:

Ausreichende Eiweißzufuhr ist für den Knochenaufbau essentiel:Adequate protein intake is for essential to build up bones:

  • 1. Aminosäuren im Eiweiß dienen als Ausgangsmaterial für die organische Knochenmatrix1. amino acids serve in protein as starting material for the organic bone matrix
  • 2. Aminosäuren besitzen spezielle Funktionen im Knochenstoffwechsel, zum Beispiel Lysin für die Calciumresorption im Darm und Arginin zum Osteoporoseschutz über die Bildung des Insulin like Growth Faktors I.2. Amino acids have special functions in bone metabolism, for example Lysine for calcium absorption in the intestine and arginine to protect against osteoporosis Formation of the insulin-like growth factor I.

Als erste Knochen zeigen Alveolarfortsatz, Oberschenkelhals und Wirbelkörper Calciumdefizite, d.h. Osteoporose, an. Durch Vitamin D und Calcium ist die Rückbildung des Alveolarknochens möglich. Zahnärzte sind oft als Erste in der Lage, Osteoporose zu erkennen und somit Prävention und Therapie rechtzeitig einzuleiten. Mit den erfindungsgemäßen Zusammensetzungen wird ih nen daher ein geeignetes Mittel in die Hand gegeben.The first bones show alveolar process, Femoral neck and vertebral body Calcium deficits, i.e. Osteoporosis. With vitamin D and calcium is regression of the alveolar bone possible. Are dentists often the first to be able to recognize osteoporosis and thus prevention and initiate therapy in time. With the compositions according to the invention they are given a suitable remedy.

Claims (10)

Zusammensetzung, umfassend einen Gehalt an Antioxidantien und Vitalstoffen sowie geeignete Hilfs- und Trägerstoffe zur prophylaktischen und/oder akuten Behandlung von Parodontitis sowie damit einhergehenden Begleit- und/oder Folgeerkrankungen.Composition comprising antioxidant content and vital substances as well as suitable auxiliary and carrier substances for prophylactic and / or acute treatment of periodontitis and related Concomitant and / or secondary diseases. Zusammensetzung nach Anspruch 1, gekennzeichnet durch einen Gehalt an Ubichinon (Q10) und Vitalstoffen, nämlich Vitaminen und/oder Mineralien.Composition according to claim 1, characterized by contains ubiquinone (Q10) and vital substances, namely vitamins and / or minerals. Zusammensetzung nach Anspruch 2, dadurch gekennzeichnet, dass die Vitamine aus der Gruppe ausgewählt sind, die aus Vitamin A, B, C, D, E und K besteht.Composition according to claim 2, characterized in that the vitamins are selected from the group consisting of vitamin A, B, C, D, E and K. Zusammensetzung nach Anspruch 2 oder 3, dadurch gekennzeichnet, das die Mineralien aus der Gruppe ausgewählt sind, die aus Calcium, Magnesium, Zink, Kupfer, Mangan, Fluor und Phosphor besteht.Composition according to claim 2 or 3, characterized in that that the minerals are selected from the group consisting of calcium, Magnesium, zinc, copper, manganese, fluorine and phosphorus exist. Zusammensetzung nach einem der Ansprüche 1 bis 4, dadurch gekennzeichnet, dass sie wenigstens eine Aminosäure umfasst.Composition according to one of claims 1 to 4, characterized in that it comprises at least one amino acid. Zusammensetzung nach Anspruch 5, dadurch gekennzeichnet, dass die Aminosäure Lysin ist.Composition according to claim 5, characterized in that the amino acid Is lysine. Verwendung der Zusammensetzung nach einem der Ansprüche 1 bis 6, in der Therapie bei akuten und chronischen Zahnfleisch- und Kiefererkrankung.Use of the composition according to any one of claims 1 to 6, in therapy for acute and chronic gum and jaw disease. Verwendung der Zusammensetzung nach einem der Ansprüche 1 bis 6 in der Osteoporoseprävention.Use of the composition according to any one of claims 1 to 6 in osteoporosis prevention. Verwendung der Zusammensetzung nach einem der Ansprüche 1 bis 6 im veterinärmedizinischen Bereich, insbesondere zur Behandlung von Paradontitis bei Hunden und Katzen.Use of the composition according to any one of claims 1 to 6 in veterinary medicine Area, especially for the treatment of periodontitis in dogs and cats. Verwendung der Zusammensetzung nach einem der Ansprüche 1 bis 6 in Form einer Paste, eines Öls oder in Form von Lutschtabletten.Use of the composition according to any one of claims 1 to 6 in the form of a paste, an oil or in the form of lozenges.
DE10257478A 2002-12-09 2002-12-09 Composition containing antioxidants and micronutrients, useful for treatment or prevention of paradontitis and associated disorders, also osteoporosis Withdrawn DE10257478A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
DE20220964U DE20220964U1 (en) 2002-12-09 2002-12-09 Composition containing antioxidants and micronutrients, useful for treatment or prevention of paradontitis and associated disorders, also osteoporosis
DE10257478A DE10257478A1 (en) 2002-12-09 2002-12-09 Composition containing antioxidants and micronutrients, useful for treatment or prevention of paradontitis and associated disorders, also osteoporosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10257478A DE10257478A1 (en) 2002-12-09 2002-12-09 Composition containing antioxidants and micronutrients, useful for treatment or prevention of paradontitis and associated disorders, also osteoporosis

Publications (1)

Publication Number Publication Date
DE10257478A1 true DE10257478A1 (en) 2004-07-08

Family

ID=32477483

Family Applications (1)

Application Number Title Priority Date Filing Date
DE10257478A Withdrawn DE10257478A1 (en) 2002-12-09 2002-12-09 Composition containing antioxidants and micronutrients, useful for treatment or prevention of paradontitis and associated disorders, also osteoporosis

Country Status (1)

Country Link
DE (1) DE10257478A1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1020183A3 (en) * 2010-08-05 2013-06-04 Eric Jan Ostwald PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT AND PREVENTION OF GINGIVITIS AND PARODONTITIS.
WO2014161872A1 (en) * 2013-04-05 2014-10-09 Nestec S.A. Compositions for use in stimulating bone growth
EP2881105A1 (en) * 2013-12-05 2015-06-10 PM-International AG Dental care product kit
DE102015102094A1 (en) 2015-01-28 2016-07-28 Madline Gund Immunosuppressive agent for use in a method for the treatment of gingivitis or periodontitis and pharmaceutical composition

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001000038A1 (en) * 1999-06-29 2001-01-04 Xel Herbaceuticals An effervescent green tea extract formulation
EP1072265A1 (en) * 1999-07-20 2001-01-31 MEDIS S.r.l. Medical Infusion Systems Use of plant polyphenols for treating iron overload
DE10109798A1 (en) * 2001-03-01 2002-09-12 Aventis Pharma Gmbh Food additives for treatment or prevention of symptoms of diabetes, osteoarthritis, osteoporosis, asthma, mental decline and age related eye disease

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001000038A1 (en) * 1999-06-29 2001-01-04 Xel Herbaceuticals An effervescent green tea extract formulation
EP1072265A1 (en) * 1999-07-20 2001-01-31 MEDIS S.r.l. Medical Infusion Systems Use of plant polyphenols for treating iron overload
DE10109798A1 (en) * 2001-03-01 2002-09-12 Aventis Pharma Gmbh Food additives for treatment or prevention of symptoms of diabetes, osteoarthritis, osteoporosis, asthma, mental decline and age related eye disease

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1020183A3 (en) * 2010-08-05 2013-06-04 Eric Jan Ostwald PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT AND PREVENTION OF GINGIVITIS AND PARODONTITIS.
WO2014161872A1 (en) * 2013-04-05 2014-10-09 Nestec S.A. Compositions for use in stimulating bone growth
JP2016520544A (en) * 2013-04-05 2016-07-14 ネステク ソシエテ アノニム Composition for use in stimulating bone growth
AU2014247122B2 (en) * 2013-04-05 2018-12-06 Société des Produits Nestlé S.A. Compositions for use in stimulating bone growth
JP2020058351A (en) * 2013-04-05 2020-04-16 ソシエテ・デ・プロデュイ・ネスレ・エス・アー Compositions for use in stimulating bone growth
US10675290B2 (en) 2013-04-05 2020-06-09 Societe Des Produits Nestle S.A. Compositions for use in stimulating bone growth
US11166965B2 (en) 2013-04-05 2021-11-09 Societe Des Produits Nestle S.A. Compositions for use in stimulating bone growth
JP2022031660A (en) * 2013-04-05 2022-02-22 ソシエテ・デ・プロデュイ・ネスレ・エス・アー Composition for use in stimulating bone growth
JP2024150494A (en) * 2013-04-05 2024-10-23 ソシエテ・デ・プロデュイ・ネスレ・エス・アー Compositions for use in stimulating bone growth - Patents.com
EP2881105A1 (en) * 2013-12-05 2015-06-10 PM-International AG Dental care product kit
DE102015102094A1 (en) 2015-01-28 2016-07-28 Madline Gund Immunosuppressive agent for use in a method for the treatment of gingivitis or periodontitis and pharmaceutical composition

Similar Documents

Publication Publication Date Title
US6503483B2 (en) Dental formulation
DE102008036954B4 (en) Use of an amino sugar-containing composition
EP0874618A1 (en) Preparation for improving hair growth, the skin structure and/or nail regeneration
KR20180089003A (en) Toothpaste composition comprising natural extracts and preparing method thereof
KR20210122554A (en) Nutritional composition for pets for prevention and improvement of periodontal disease and nutritional agent manufactured thereby
US20040214750A1 (en) Medicaments for healing skin conditions in humans
CN106691883A (en) Toothpaste and preparation method thereof
KR101517095B1 (en) Periodontal diseases treatment and prevention composition using the natural extracts
WO2002076433A1 (en) Dental formulation
KR102377359B1 (en) Soap compositions containing natural ingredients
DE102015218892A1 (en) Application mixture for increasing the effect of antiseptics and / or disinfectants, application agent with the content of the application mixture and the use of this mixture
DE10257478A1 (en) Composition containing antioxidants and micronutrients, useful for treatment or prevention of paradontitis and associated disorders, also osteoporosis
CN108434174B (en) A kind of oral spray for assisting dental caries treatment and prevention of dental caries and preparation method thereof
DE4028957C2 (en) Therapeutic for the mouth area
EP0757554B1 (en) Lollipop with tooth plaque neutralising effect
DE20220964U1 (en) Composition containing antioxidants and micronutrients, useful for treatment or prevention of paradontitis and associated disorders, also osteoporosis
KR20230040932A (en) Composition for removing or improving oral malodor
WO2010082600A1 (en) Agent for maintaining healthy state of periodontal tissue comprising oleuropein and degraded product thereof
Abuljadayel The Potential Uses of Baobab Tree's Medicinal Effects in Dentistry: A Literature Review
Ramya et al. Anti inflammatory and antioxidant activity of Stevia and peppermint herbal formulation
KR101910716B1 (en) Mouthwash containing green tea
DE102020104279A1 (en) Collagen hydrolyzate as an active ingredient against periodontitis or gingivitis
US20210290711A1 (en) Hempseed oil compositions
EP2900209B1 (en) Composition containing lysine as a nutritional supplement or treatment in the case of herpes
DE3821922A1 (en) Pharmaceutical foodstuff for curative purposes and process for its production

Legal Events

Date Code Title Description
OP8 Request for examination as to paragraph 44 patent law
8130 Withdrawal
8165 Unexamined publication of following application revoked